Acute Respiratory Distress Syndrome Devices Market

Acute Respiratory Distress Syndrome Devices Market (Type: Therapeutic Devices and Diagnostic & Monitoring Devices) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Global Acute Respiratory Distress Syndrome Devices Market Outlook 2031

  • The global industry was valued at US$ 311.1 Mn in 2021
  • It is projected to grow at a CAGR of 7.8% from 2022 to 2031 and reach more than US$ 651.6 Mn by the end of 2031

Analysts’ Viewpoint on Market Scenario

Rise in the incidence of acute respiratory distress syndrome (ARDS) is expected to drive the acute respiratory distress syndrome devices market size from 2022 to 2031. ARDS is a serious lung condition that causes fluid to build up in the air sacs of the lungs. Elderly people are highly susceptible to suffer from this condition. Therefore, surge in the geriatric population is anticipated to boost market expansion during the forecast period.

Investment in the R&D of new devices is estimated to offer lucrative growth opportunities for vendors in the industry. However, high costs and a lack of trained personnel are likely to limit adoption of ARDS devices in the near future. Vendors are focused on the launch of affordable devices to increase their acute respiratory distress syndrome devices market share.

Acute Respiratory Distress Syndrome Devices Market

Market Introduction

Acute respiratory distress syndrome (ARDS) is a severe lung condition that can occur as a complication of a wide range of underlying conditions, including sepsis, pneumonia, and trauma. It is characterized by inflammation and fluid accumulation in the lungs, which can lead to difficulty in breathing and low oxygen levels in the blood.

ARDS can be life-threatening if not treated promptly and effectively. Various devices and equipment are used for the treatment of ARDS including mechanical ventilators, oxygen therapy devices, and extracorporeal membrane oxygenation (ECMO) systems. ARDS devices are typically employed in critical care settings such as intensive care units (ICUs) and emergency departments.

Rise in Incidence of ARDS Augmenting Acute Respiratory Distress Syndrome Devices Market Development

Aging population and surge in cases of chronic diseases are estimated to boost the demand for ARDS devices in the next few years. People above the age of 60 years are at high risk of ARDS and other chronic conditions. According to the United Nations, the global population aged 60 years and above is projected to more than double by 2050.

Older adults are susceptible to various chronic diseases such as obesity, diabetes, and heart disease. Additionally, they are more likely to have weakened immune systems, making them more prone to infections such as pneumonia. According to the World Health Organization (WHO), ARDS affects around 150 million people globally every year. Thus, high prevalence of ARDS is estimated to aid in acute respiratory distress syndrome devices business growth in the near future.

R&D of New Devices

Major acute respiratory distress syndrome device manufacturers are focused on investing significantly in the R&D of new products. Advanced ARDS devices are likely to improve patient outcomes, reduce the length of hospital stays, and lower healthcare costs.

In June 2020, Hamilton Medical launched the Hamilton-T1 ventilator with High-Frequency Oscillation Ventilation (HFOV) technology to provide advanced ventilation support for critically ill patients. HFOV is a form of mechanical ventilation that delivers rapid, small tidal volume breaths at a high frequency. This helps minimize lung injury and improve patient outcomes. Therefore, development and launch of new devices is projected to augment the acute respiratory distress syndrome devices market trajectory in the next few years.

Increase in Adoption of Diagnostic & Monitoring Devices

According to the latest acute respiratory distress syndrome devices market trends, the diagnostic & monitoring devices type segment is anticipated to hold largest share during the forecast period. Diagnostic & monitoring devices are utilized for the treatment and management of ARDS. High prevalence of ARDS is likely to boost the demand for these devices in the near future.

Diagnostic & monitoring devices measure oxygen saturation levels, lung function, and other vital signs. This enables healthcare professionals to initiate prompt and effective treatment. Early detection and treatment of ARDS can improve patient outcomes and reduce the length of hospital stays.

Hospitals Primarily Provide Care for ARDS Patients

The hospitals end-user segment is estimated to dominate the acute respiratory distress syndrome devices market during the forecast period. Hospitals are the primary providers of care for patients with ARDS. These patients typically require hospitalization and close monitoring, which is only possible in a hospital setting.

Hospitals possess the required infrastructure and resources to support the use of ARDS devices. They also have the necessary personnel, including doctors, nurses, and respiratory therapists, needed to operate these devices. Robust infrastructure further allows hospitals to offer the best possible care for ARDS patients.

Regional Outlook

According to the latest acute respiratory distress syndrome devices market analysis, North America is anticipated to hold largest share during the forecast period. Increase in the incidence of ARDS and other respiratory disorders, rise in healthcare expenditure, and the presence of major vendors are likely to boost market progress in the near future.

The industry in Asia Pacific market is projected to grow at a significant rate during the forecast period. High prevalence of respiratory disorders, surge in the geriatric population, and growth in awareness regarding advanced ARDS devices are expected to augment market statistics in the region.

Analysis of Key Players

Major vendors have been profiled in the acute respiratory distress syndrome devices market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Koninklijke Philips N.V., Medtronic, Fisher & Paykel Healthcare Limited, Drägerwerk AG & Co. KGaA, Smiths Medical (ICU Medical), Hamilton Medical, GE Healthcare, ResMed, and Getinge AB are key entities operating in this industry. Companies are focused on adopting various organic and inorganic strategies to broaden their regional presence.

Key Developments in Acute Respiratory Distress Syndrome Devices Market

  • In January 2021, Fisher & Paykel Healthcare Limited launched its new Optiflow+ nasal high flow therapy system, which is designed to provide respiratory support to patients with ARDS and other respiratory conditions

Acute Respiratory Distress Syndrome Devices Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 311.1 Mn

Market Forecast Value in 2031

More than US$ 651.6 Mn

Compound Annual Growth Rate (CAGR)

7.8%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Mn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis/ranking by company (2021)
  • Company profiles section includes overview, product portfolio, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Type
    • Therapeutic Devices
      • Mechanical Ventilators
      • PAP
      • Others
    • Diagnostic & Monitoring Devices
  • End-user
    • Hospitals
    • Specialty Centers
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Koninklijke Philips N.V.
  • Medtronic
  • Fisher & Paykel Healthcare Limited
  • Drägerwerk AG & Co. KGaA
  • Smiths Medical (ICU Medical)
  • Hamilton Medical
  • GE HealthCare
  • ResMed
  • Getinge AB
  • Other prominent players

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global acute respiratory distress syndrome devices market in 2021?

The global market was valued at US$ 311.1 Mn in 2021.

How big will the market be in 2031?

It is projected to reach more than US$ 651.6 Mn by 2031.

What will be the CAGR during the forecast period?

It is anticipated to be 7.8% from 2022 to 2031.

Which are the prominent trends that affect business growth?

Rise in incidence of Acute Respiratory Distress Syndrome (ARDS) and increase in geriatric population.

Which segment dominated the industry?

The diagnostic & monitoring devices segment held largest share in 2021.

Which region will account for major share during the forecast period?

North America is expected to account for major share from 2022 to 2031.

Who are the prominent players operating in the market?

Koninklijke Philips N.V., Medtronic, Fisher & Paykel Healthcare Limited, Drägerwerk AG & Co. KGaA, Smiths Medical (ICU Medical), Hamilton Medical, GE Healthcare, ResMed, and Getinge AB.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Acute Respiratory Distress Syndrome Devices Market

    4. Market Overview

        4.1. Overview

        4.2. Market Dynamics

            4.2.1. Drivers

            4.2.2. Restraints

            4.2.3. Opportunities

        4.3. Global Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast, 2017–2031

    5. Key Insight

        5.1. Disease Incidence and prevalence

        5.2. Key Mergers & Acquisitions

        5.3. New Product Launches and FDA Approvals

        5.4. COVID-19 Impact Analysis

    6. Global Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast, by Type

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Global Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031

            6.3.1. Therapeutic Devices

                6.3.1.1. Mechanical Ventilators

                6.3.1.2. PAP

                6.3.1.3. Others

            6.3.2. Diagnostic & Monitoring Devices

        6.4. Global Acute Respiratory Distress Syndrome Devices Market Attractiveness, by Type

    7. Global Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast, by End-user

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Global Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031

            7.3.1. Hospitals

            7.3.2. Specialty Centers

            7.3.3. Others

        7.4. Global Acute Respiratory Distress Syndrome Devices Market Attractiveness, by End-user

    8. Global Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Global Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Region

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. Global Acute Respiratory Distress Syndrome Devices Market Attractiveness, by Region

    9. North America Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. North America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031

            9.2.1. Therapeutic Devices

                9.2.1.1. Mechanical Ventilators

                9.2.1.2. PAP

                9.2.1.3. Others

            9.2.2. Diagnostic & Monitoring Devices

        9.3. North America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031

            9.3.1. Hospitals

            9.3.2. Specialty Centers

            9.3.3. Others

        9.4. North America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Country, 2017–2031

            9.4.1. U.S.

            9.4.2. Canada

        9.5. North America Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis

            9.5.1. By Type

            9.5.2. By End-user

            9.5.3. By Country

    10. Europe Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Europe Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031

            10.2.1. Therapeutic Devices

                10.2.1.1. Mechanical Ventilators

                10.2.1.2. PAP

                10.2.1.3. Others

            10.2.2. Diagnostic & Monitoring Devices

        10.3. Europe Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031

            10.3.1. Hospitals

            10.3.2. Specialty Centers

            10.3.3. Others

        10.4. Europe Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Country/Sub-region, 2017–2031

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Spain

            10.4.5. Italy

            10.4.6. Rest of Europe

        10.5. Europe Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis

            10.5.1. By Type

            10.5.2. By End-user

            10.5.3. By Country/Sub-region

    11. Asia Pacific Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031

            11.2.1. Therapeutic Devices

                11.2.1.1. Mechanical Ventilators

                11.2.1.2. PAP

                11.2.1.3. Others

            11.2.2. Diagnostic & Monitoring Devices

        11.3. Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031

            11.3.1. Hospitals

            11.3.2. Specialty Centers

            11.3.3. Others

        11.4. Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Country/Sub-region, 2017–2031

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific

        11.5. Asia Pacific Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis

            11.5.1. By Type

            11.5.2. By End-user

            11.5.3. By Country/Sub-region

    12. Latin America Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Latin America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031

            12.2.1. Therapeutic Devices

                12.2.1.1. Mechanical Ventilators

                12.2.1.2. PAP

                12.2.1.3. Others

            12.2.2. Diagnostic & Monitoring Devices

        12.3. Latin America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031

            12.3.1. Hospitals

            12.3.2. Specialty Centers

            12.3.3. Others

        12.4. Latin America Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Country/Sub-region, 2017–2031

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America

        12.5. Latin America Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis

            12.5.1. By Type

            12.5.2. By End-user

            12.5.3. By Country/Sub-region

    13. Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Type, 2017–2031

            13.2.1. Therapeutic Devices

                13.2.1.1. Mechanical Ventilators

                13.2.1.2. PAP

                13.2.1.3. Others

            13.2.2. Diagnostic & Monitoring Devices

        13.3. Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value Forecast, by End-user, 2017–2031

            13.3.1. Hospitals

            13.3.2. Specialty Centers

            13.3.3. Others

        13.4. Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value Forecast, by Country/Sub-region, 2017–2031

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa

        13.5. Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis

            13.5.1. By Type

            13.5.2. By End-user

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player – Competition Matrix (By Tier and Size of Companies)

        14.2. Market Share Analysis By Company (2021)

        14.3. Company Profiles

            14.3.1. Koninklijke Philips N.V.

                14.3.1.1. Company Overview

                14.3.1.2. Product Portfolio

                14.3.1.3. SWOT Analysis

                14.3.1.4. Financial Overview

                14.3.1.5. Strategic Overview

            14.3.2. Medtronic

                14.3.2.1. Company Overview

                14.3.2.2. Product Portfolio

                14.3.2.3. SWOT Analysis

                14.3.2.4. Financial Overview

                14.3.2.5. Strategic Overview

            14.3.3. Fisher & Paykel Healthcare Limited

                14.3.3.1. Company Overview

                14.3.3.2. Product Portfolio

                14.3.3.3. SWOT Analysis

                14.3.3.4. Financial Overview

                14.3.3.5. Strategic Overview

            14.3.4. Drägerwerk AG & Co. KGaA

                14.3.4.1. Company Overview

                14.3.4.2. Product Portfolio

                14.3.4.3. SWOT Analysis

                14.3.4.4. Financial Overview

                14.3.4.5. Strategic Overview

            14.3.5. Smiths Medical (ICU Medical)

                14.3.5.1. Company Overview

                14.3.5.2. Product Portfolio

                14.3.5.3. SWOT Analysis

                14.3.5.4. Financial Overview

                14.3.5.5. Strategic Overview

            14.3.6. Hamilton Medical

                14.3.6.1. Company Overview

                14.3.6.2. Product Portfolio

                14.3.6.3. SWOT Analysis

                14.3.6.4. Strategic Overview

            14.3.7. GE HealthCare

                14.3.7.1. Company Overview

                14.3.7.2. Product Portfolio

                14.3.7.3. SWOT Analysis

            14.3.8. ResMed

                14.3.8.1. Company Overview

                14.3.8.2. Product Portfolio

                14.3.8.3. SWOT Analysis

                14.3.8.4. Strategic Overview

            14.3.9. Getinge AB

                14.3.9.1. Company Overview

                14.3.9.2. Product Portfolio

                14.3.9.3. SWOT Analysis

                14.3.9.4. Strategic Overview

    List of Tables

    Table 01: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 02: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031

    Table 03: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 04: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 06: North America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031

    Table 07: North America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 08: North America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 09: Europe Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 10: Europe Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031

    Table 11: Europe Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 12: Europe Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 13: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 14: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031

    Table 15: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 16: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 17: Latin America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 18: Latin America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031

    Table 19: Latin America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 20: Latin America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 21: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 22: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Therapeutic Devices, 2017–2031

    Table 23: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 24: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    List of Figures

    Figure 01: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) and Distribution (%), by Region, 2021 and 2031

    Figure 02: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn), by Type, 2021

    Figure 03: Market Snapshot - Top 2 Trends

    Figure 04: Market Overview

    Figure 05: Global Acute Respiratory Distress Syndrome Devices Market Value Share, by Type, 2021

    Figure 06: Global Acute Respiratory Distress Syndrome Devices Market Value Share, by End-user, 2021

    Figure 07: Global Acute Respiratory Distress Syndrome Devices Market Value Share, by Region, 2021

    Figure 08: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast, 2017–2031

    Figure 09: Global Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Type, 2021 and 2031

    Figure 10: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) and Y-o-Y Growth, by Therapeutic Devices, 2017–2031

    Figure 11: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) and Y-o-Y Growth, by Diagnostic & Monitoring Devices, 2017–2031

    Figure 12: Global Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Type, 2021–2031

    Figure 13: Global Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 14: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2017–2031

    Figure 15: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Specialty Centers, 2017–2031

    Figure 16: Global Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2031

    Figure 17: Global Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 18: Global Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Region, 2021 and 2031

    Figure 19: Global Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Region, 2021–2031

    Figure 20: North America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 21: North America Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Type, 2021 and 2031

    Figure 22: North America Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Type, 2021–2031

    Figure 23: North America Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 24: North America Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 25: North America Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Country, 2021 and 2031

    Figure 26: North America Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Country, 2021–2031

    Figure 27: Europe Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 28: Europe Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Type, 2021 and 2031

    Figure 29: Europe Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Type, 2021–2031

    Figure 30: Europe Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 31: Europe Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 32: Europe Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 33: Europe Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 34: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 35: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Type, 2021 and 2031

    Figure 36: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Type, 2021–2031

    Figure 37: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 38: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 39: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 40: Asia Pacific Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 41: Latin America Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 42: Latin America Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Type, 2021 and 2031

    Figure 43: Latin America Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Type, 2021–2031

    Figure 44: Latin America Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 45: Latin America Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 46: Latin America Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 47: Latin America Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 48: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 49: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Type, 2021 and 2031

    Figure 50: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Type, 2021–2031

    Figure 51: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 52: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 53: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 54: Middle East & Africa Acute Respiratory Distress Syndrome Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Copyright © Transparency Market Research, Inc. All Rights reserved